Project Grant HT94252310127
Award Date 3/1/23
Completion Date 2/28/26
Dollars Obligated $1.4M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
- The University of Wisconsin-Madison will receive $1.17 million over four years through a Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund research to interrogate the intersection of prostate-specific membrane antigen and PI3K pathway signaling as a novel treatment approach for treatment-resistant prostate cancer. The University will investigate medical solutions for prostate cancer with the goals of transforming patient...
- Federal Grant Award Summary The University of Wisconsin-Madison received a $465,935 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2027. The project, titled "Combining 225Ac-PSMA and BRD4 Disruption to Overcome Resistance in Advanced Prostate Cancer," supports biomedical research aimed at developing novel therapeutic approaches for treatment-resistant prostate...
- Federal Grant Award Summary The University of Wisconsin – Madison received a $855,185 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) beginning September 1, 2025 and concluding August 31, 2028. This award funds research to elucidate the role of cross-talk between sensory neurons and malignant cells via CGRP-RAMP1 signaling in melanoma progression. The research will deliver hypothesis-driven biomedical investigation...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded the University of Wisconsin–Madison a $1,074,650 project grant under the Military Medical Research and Development program (CFDA 12.420) on September 1, 2025, with an ultimate completion date of August 31, 2029. The grant supports investigation of the immunomodulatory effects of chemokine signaling in renal cell carcinoma, representing a hypothesis-driven biomedical research initiative designed to advance innovative...
- Federal Grant Award Summary The University of Wisconsin–Madison received a $777,500 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2025 through May 31, 2028. This award supports a multiomic analysis research initiative focused on liquid biopsies for biomarker discovery and therapeutic targeting. The project will deliver advanced biomedical research capabilities aimed at identifying and...
- The Defense Health Agency awarded a $1,555,000 project grant to the University of Wisconsin System for the "Population Modeling to Optimize Equitable Ovarian Cancer Outcomes" research program under the Military Medical Research and Development (CFDA 12.420) federal grant program. The project, running from April 2025 to April 2029, will focus on advanced biomedical research to transform healthcare for military service members, veterans, and the public by developing novel diagnostic...
- Federal Grant Award Summary The University of Wisconsin-Madison received a $729,778 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) beginning June 1, 2025 and concluding May 31, 2028. The award supports multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting—research aimed at identifying and developing novel diagnostic markers and treatment approaches through comprehensive molecular...
- The University of Wisconsin System was awarded a $995,076 project grant by the U.S. Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support the development of new agents for the treatment of hormone receptor positive and HER2 positive breast cancer. The grant was awarded on Dec 15, 2023 and is scheduled for completion on Dec 14, 2026. As part of this project, the University of Wisconsin System has sub-awarded funding to Loyola University of...
- Federal Grant Award Summary The University of Wisconsin – Madison received a $500,000 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), awarded August 1, 2025, with performance through July 31, 2027. The project delivers research and development services focused on developing and testing a novel immune inhibitory transgene for delivery to vascular composite allografts during normothermic preservation. The primary objective...
- Federal Project Grant Award Summary The University of Wisconsin-Madison received a $1.23M Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025 through July 31, 2028. The award supports research focused on developing PET/CT (Positron Emission Tomography/Computed Tomography) radiotracers labeled with Calcium-9 (Ca9) to identify high-risk patients with clear cell renal cell carcinoma. This...